ClearPoint Neuro Inc vs Strategy Inc. — how do they compare? ClearPoint Neuro Inc trades at $14.72 (market cap $454.21M), while Strategy Inc. trades at $96.94 (market cap $37.84B). The key difference: Strategy Inc. is far larger — about 83.3× ClearPoint Neuro Inc's market cap, and ClearPoint Neuro Inc is trading nearer its 52-week high, Strategy Inc. nearer its low. Which is the better fit depends on your goals.
| CLPT | MSTR | |
|---|---|---|
Market Cap | $454.21M | $37.84B |
Sector | Health | Technology |
52-Week High | $29.60 | $394.39 |
52-Week Low | $8.66 | $82.31 |
Enterprise Value | $488.79M | $56.61B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MSTR trades at $97.33, down 2.68% on the day, with a bearish technical signal and weak fundamentals including a negative net income margin of -6,102.96% and three consecutive quarterly earnings misses. The company's performance remains heavily influenced by its Bitcoin holdings, with recent news highlighting Bitcoin sales to fund stock buybacks and address capital structure concerns.
The outlook is mixed: analyst consensus is bullish with a $210 price target, but high leverage, volatile Bitcoin exposure, and persistent losses pose significant risks. Investment appeal hinges on Bitcoin's recovery and management's ability to stabilize finances, making it speculative for equity investors.
Trailing returns across standard periods
Latest headlines on both assets
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →